ストックスクリーナーアプリを入手
208.61
1.30%
-1.8757
前日終値:
$210.49
開ける：
$207.15
24時間の取引高:
284.09K
Relative Volume:
0.18
時価総額：
$34.78B
収益：
$16.63B
当期純損益:
$1.39B
株価収益率:
25.86
EPS:
8.0674
ネットキャッシュフロー:
$2.12B
1週間 パフォーマンス:
-0.05%
1か月 パフォーマンス:
+21.73%
6か月 パフォーマンス:
-12.59%
1年 パフォーマンス:
+27.26%
1日の値動き範囲:
$206.53
$211.64
1週間の範囲:
$202.76
$212.36
52週間の値動き範囲:
$154.50
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Compare IQV vs TMO, DHR, IDXX, A, NTRA
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
208.39 | 35.13B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
533.52 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
203.53 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
567.32 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
132.27 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
NTRA
Natera Inc
|
263.62 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-09 | アップグレード | TD Cowen | Hold → Buy |
| 2026-03-06 | アップグレード | Barclays | Equal Weight → Overweight |
| 2026-03-03 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-11-13 | 開始されました | BMO Capital Markets | Outperform |
| 2025-11-03 | ダウングレード | TD Cowen | Buy → Hold |
| 2025-10-29 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-09 | アップグレード | Jefferies | Hold → Buy |
| 2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-10 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2025-02-03 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-12-20 | 開始されました | Stephens | Overweight |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-09-04 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-07-24 | ダウングレード | Jefferies | Buy → Hold |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-15 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-02-13 | 開始されました | BTIG Research | Buy |
| 2023-11-02 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | 開始されました | HSBC Securities | Buy |
| 2023-03-17 | 開始されました | Truist | Buy |
| 2022-12-06 | 開始されました | Cowen | Outperform |
| 2022-11-17 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-07-15 | 開始されました | SVB Leerink | Outperform |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-29 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-04-16 | アップグレード | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2020-07-07 | 開始されました | Stephens | Equal-Weight |
| 2020-03-02 | 開始されました | Deutsche Bank | Buy |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-12-13 | アップグレード | CFRA | Sell → Hold |
| 2019-11-14 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | アップグレード | Mizuho | Neutral → Buy |
| 2019-05-28 | 開始されました | SVB Leerink | Outperform |
| 2019-01-18 | アップグレード | Jefferies | Hold → Buy |
| 2018-10-09 | 開始されました | UBS | Buy |
| 2018-10-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2018-07-25 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | 繰り返されました | Stifel | Buy |
| 2018-07-03 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | アップグレード | Goldman | Neutral → Buy |
| 2018-03-07 | アップグレード | SunTrust | Hold → Buy |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Iqvia Holdings Inc (IQV) 最新ニュース
IQVIA Holdings stock trades steadily as data-driven growth supports valuations - ad-hoc-news.de
Form 4 IQVIA Holdings Inc For: 16 July By Investing.com - Investing.com Canada
IQVIA Holdings (NYSE: IQV) grants director 148 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) grants director 183 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) grants director 195 deferred shares - Stock Titan
IQVIA Holdings (NYSE: IQV) awards director 160 deferred share units - Stock Titan
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
IQVIA Seeks Faster Path From Discovery to Human Drug Trials - Stock Titan
IQVIA Holdings' Q2 2026 earnings: What to expect - MSN
IQVIA Holdings (IQV) Q1 2026 Earnings Call Transcript - Fortune
Global Clinical Trials Market to Reach $176.32 Billion by 2030 as AI and Decentralized Research Accelerate Growth - GlobeNewswire Inc.
IQVIA Holdings stock reflects data-driven growth in global healthcare analytics - ad-hoc-news.de
Is IQVIA Holdings stock outperforming the Dow? - MSN
IQV vs. PEN: Which Stock Is the Better Value Option? - Yahoo! Finance Canada
IQVIA stock holds steady as its data and research model stays central - ad-hoc-news.de
IQVIA Holdings Inc. (IQV) Q1 2026 Earnings: EPS Surpasses Street Estimates, Shares Edge HigherGuidance Accuracy Score - dars.gov.et
Mizuho Adjusts Price Target on IQVIA Holdings to $230 From $215, Maintains Outperform Rating - marketscreener.com
Mizuho Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $230 - Moomoo
IQV Maintained by Mizuho -- Price Target Raised to $230 - GuruFocus
IQVIA Holdings, Inc. (IQV) Stock Analysis: Strong Analyst Consensus and a 10% Upside Potential - DirectorsTalk Interviews
IQVIA stock steadies as data-driven health services underpin long-term growth - Ad-hoc-news.de
Why is Larry Robbins Bullish on IQVIA Holdings (IQV) Amid Market Volatility - Kavout | AI
Analysts Are Neutral on Top Healthcare Stocks: IQVIA Holdings (IQV), Qiagen (QGEN) - The Globe and Mail
IQVIA HOLDINGS INC CMNRo Khanna Congressional Trade on Jun. 02, 2026 - Quiver Quantitative
Did Artisan’s New Stake in IQVIA (IQV) Reframe Its AI and Data Recurring-Revenue Story? - Sahm
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQV News | IQVIA HOLDINGS INC (NYSE:IQV) - ChartMill
IQVIA stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA (IQV) Just Drew A New Artisan Partners Bet On AI And Resilience - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
IQVIA Holdings stock stays supported by data-driven healthcare demand - ad-hoc-news.de
IQVIA Holdings (IQV) Draws Undervalued Attention, Is The Recent Momentum Fully Priced In? - Sahm
IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 - BioSpace
IQVIA to announce Q2FY26 results on July 28, 2026 - scanx.trade
RBC Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $221 - Moomoo
IQVIA Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Is IQVIA Holdings (IQV) Resilient to AI Concerns? - Yahoo Finance
(IQV) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IQVIA stock holds its line as investors await a fresh catalyst. - AD HOC NEWS
Evercore ISI Adjusts Price Target on IQVIA Holdings Inc to $225 From $195 - Moomoo
Argus Adjusts Price Target on IQVIA Holdings to $235 From $215 - marketscreener.com
HSBC Adjusts Price Target on IQVIA Holdings Inc to $240 From $210 - Moomoo
IQVIA stock steadies on a thin catalyst day. - Ad-hoc-news.de
IQVIA Holdings, Inc. (IQV) Investor Outlook: Analyzing Growth Potential With A 9.39% Upside - DirectorsTalk Interviews
IQVIA stock holds focus on its data and services model. - Ad-hoc-news.de
IQVIA board authorizes additional $2 billion stock buyback - Investing.com
IQVIQVIA Holdings Inc Volatility & Greeks - Finviz
The IQVIA CORE – IQVIA Holdings leans on real-world data backbone - AD HOC NEWS
MidCap Value Fund I's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc outlook and operations as a healthcare data leader - Ad-hoc-news.de
Iqvia Holdings Inc (IQV) 財務データ
収益
当期純利益
現金流量
EPS
0.06%
大文字化:
|
ボリューム (24 時間):